Patients
8 per 100,000 people
Tuberculosis new cases, New Zealand, 2024 (World Bank).
Compare every country on the Public Health Dashboard
Updated
Reviewed by Chandani Patel
New Zealand Tuberculosis Diagnostics Market Industry Trends and Forecast to 2034: Segmented by (Test, Setting, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$21.2 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $26.7 Mn | — | — |
| 2025 (base) | $28.4 Mn | +$1.7 Mn | — |
| 2026 (forecast) | $30.2 Mn | +$1.8 Mn | +6.4% |
| 2027 (forecast) | $32.2 Mn | +$1.9 Mn | +13.2% |
| 2028 (forecast) | $34.2 Mn | +$2.1 Mn | +20.5% |
| 2029 (forecast) | $36.4 Mn | +$2.2 Mn | +28.2% |
| 2030 (forecast) | $38.7 Mn | +$2.3 Mn | +36.4% |
| 2031 (forecast) | $41.2 Mn | +$2.5 Mn | +45.1% |
| 2032 (forecast) | $43.9 Mn | +$2.6 Mn | +54.4% |
| 2033 (forecast) | $46.7 Mn | +$2.8 Mn | +64.3% |
| 2034 (forecast) | $49.7 Mn | +$3.0 Mn | +74.8% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $28.4 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $49.7 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 6.4% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Test, setting and end user (see all) |
| Key players | Cepheid, Qiagen N.V., Molbio Diagnostics, Qure.ai, Revvity (see all) |
| Regulator in New Zealand | Medsafe (WAND)Source: Medsafe. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Tuberculosis diagnostics find TB infection and disease using skin tests, blood tests, molecular tests and chest X-ray reading.
Key segments of the tuberculosis Diagnostics market include test (Molecular Tests, Interferon Gamma Release Assays and Skin Tests) and setting (Hospitals, TB Programs and Point of Care).
Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the tuberculosis Diagnostics market.
Home testing, connected devices that send results to doctors and multiplex tests that check many conditions at once give the tuberculosis Diagnostics market room to grow, especially in emerging markets.
Pricing pressure, uneven reimbursement for new tests, regulatory approval times and the need for skilled lab staff hold back the tuberculosis Diagnostics market.
The tuberculosis Diagnostics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medical devices do not need approval before sale, but suppliers must notify them to the WAND database run by Medsafe.[1] Pharmac decides which medicines and medical devices the public health system pays for.[2] Tuberculosis new cases: 8 per 100,000 people in 2024, the latest World Bank figure for New Zealand.[3]
[1] Medsafe. Checked 14 Nov 2026.
[2] Pharmac. Checked 14 Nov 2026.
[3] World Bank Open Data, Tuberculosis new cases (per 100,000 people). Retrieved 21 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how tuberculosis Diagnostics products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in New Zealand.
What doctors and scientists are doing in Tuberculosis Diagnostics right now, from free public sources.
8 per 100,000 people
Tuberculosis new cases, New Zealand, 2024 (World Bank).
Compare every country on the Public Health DashboardSources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 21 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Tuberculosis new cases (per 100,000 people). Retrieved 21 Nov 2026.
[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 22 Nov 2026.
[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 21 Nov 2026.
From our blog
New Zealand · 1 shared keyword
New Zealand · 1 shared keyword
New Zealand · 1 shared keyword
New Zealand · 1 shared keyword
New Zealand · 1 shared keyword
New Zealand · 1 shared keyword
Digital Health · New Zealand
Healthcare Services · New Zealand
Healthcare Services · New Zealand
Pharmaceuticals · New Zealand
Healthcare Services · New Zealand
Healthcare Services · New Zealand